Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pioneering 'String Test' a True Game Changer in Gastrointestinal Monitoring

By HospiMedica International staff writers
Posted on 01 Sep 2022

A care-changing test is designed to monitor inflammation of the gastrointestinal (GI) tract by painlessly collecting samples while the patient remains awake and alert. More...

This saves patients more costly and invasive testing that includes having to receive anesthesia.

The EnteroTracker – commonly referred to as the “string test” – from EnteroTrack LLC (Aurora, CO, USA) provides low-cost, accurate analysis of esophageal content and identifies the presence of esophageal inflammation. This allows providers to monitor the effectiveness of treatment. The string test is simple: The patient simply swallows a secured capsule that is composed of a specialty string. As it makes its way to the small intestine, the string continues to unravel. After a few minutes of comfortable rest for the patient, the clinician can gently remove the string, use pH and distance marking to identify sections of the string that correspond to the GI tract, and send the string to the lab for analysis.

The test has been shown to be effective in monitoring inflammatory eosinophilic esophagitis (EoE) and may have uses in other diseases including severe gastroesophageal reflux (GERD), eosinophilic gastroenteritis (EGE), food allergic enteropathy (FAE) and inflammatory bowel disease (lBD). These diseases can be difficult to monitor with blood tests, and radio-imaging cannot sample these parts of the GI tract easily.

“I began this project when I joined Children’s Colorado in 2007,” said pediatric gastroenterologist Glenn T. Furuta, MD, of the pediatric hospital system's Digestive Health Institute and Gastrointestinal Eosinophilic Diseases Program, who was among the team of researchers that developed the test. “We knew there had to be options to save our patients from having to go under anesthesia in order to obtain results that would tell us much-needed information about their conditions. We are thrilled at the outcome of this product and the real changes in care this will provide not just our patients, but patients across the country as this technology becomes available for other hospitals to use. It’s truly a game changer in the delivery of care.”

 

 


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.